Skip to main content
Log in

Studies of Anandamide Accumulation Inhibitors in Cerebellar Granule Neurons: Comparison to Inhibition of Fatty Acid Amide Hydrolase

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The endocannabinoid, N-arachidonylethanolamine (AEA) is accumulated by neurons via a process that has been characterized biochemically but not molecularly. Inhibitors of AEA accumulation have been characterized individually but have not been compared in a single study. Our purpose was to compare the potency of five previously described compounds (AM404, AM1172, VDM11, OMDM-2, and UCM707) both as inhibitors of AEA and N-palmitoylethanolamine (PEA) accumulation by cerebellar granule neurons and as inhibitors of AEA hydrolysis. The compounds all inhibited AEA accumulation; AM404, VDM11 and OMDM-2 with IC50 values of approximately 5 μM, whereas AM1172 and UCM707 exhibited IC50 values of 24 and 30 μM, respectively. The compounds also inhibited PEA accumulation; AM404 being the most potent with an IC50 of 6 μM, whereas the other compounds had IC50 values in the range of 30–70 μM. All of the compounds potently inhibited AEA hydrolysis by brain membranes; the K I values for AM404, VDM11, and UCM707 were less than 1 μM; AM1172 and OMDM-2 exhibited K I values of 3 and 10 μM, respectively. The IC50 values for inhibition of AEA accumulation were compared to the IC50 values for PEA accumulation and AEA hydrolysis using linear regression. None of the regressions were significant. These data indicate that inhibition of AEA accumulation by neurons is not a result of the inhibition of endocannabinoid hydrolysis and is a process different from the accumulation of PEA. These studies support the hypothesis that the cellular AEA accumulation beyond simple equilibrium between intracellular and extracellular concentrations occurs because AEA binds to an intracellular protein that is not FAAH but that also recognizes the AEA uptake inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Beltramo, M., di Tomaso, E., & Piomelli, D. (1997a). Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one. Federation of European Biochemical Societies letters, 403, 263–267.

    PubMed  CAS  Google Scholar 

  • Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997b). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094–1097.

    Article  PubMed  CAS  Google Scholar 

  • Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001). Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Molecular Pharmacology, 59, 1369–1375.

    PubMed  CAS  Google Scholar 

  • De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity. Federation of European Biochemical Societies letters, 483, 52–56.

    PubMed  Google Scholar 

  • Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., et al. (2004). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the United States of America, 101, 8756–8761.

    Article  PubMed  CAS  Google Scholar 

  • Fowler, C. J., Tiger, G., Ligresti, A., Lopez-Rodriguez, M. L., & Di Marzo, V. (2004). Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle. European Journal of Pharmacology, 492, 1–11.

    Article  PubMed  CAS  Google Scholar 

  • Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003). Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the United States of America, 100, 4269–4274.

    Article  PubMed  CAS  Google Scholar 

  • Hillard, C. J., & Jarrahian, A. (2003). Cellular accumulation of anandamide: Consensus and controversy. British Journal of Pharmacology, 140, 802–808.

    Article  PubMed  CAS  Google Scholar 

  • Hillard, C. J., & Jarrahian, A. (2005). Accumulation of anandamide: Evidence for cellular diversity. Neuropharmacology, 48, 1072–1078.

    Article  PubMed  CAS  Google Scholar 

  • Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995). Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochimica et Biophysica Acta, 1257, 249–256.

    PubMed  Google Scholar 

  • Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry, 69, 631–638.

    Article  PubMed  CAS  Google Scholar 

  • Jacobsson, S. O., & Fowler, C. J. (2001). Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: Comparison with anandamide. British Journal of Pharmacology, 132, 1743–1754.

    Article  PubMed  CAS  Google Scholar 

  • Jarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000). Structure–activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. Journal of Neurochemistry, 74, 2597–2606.

    Article  PubMed  CAS  Google Scholar 

  • Lang, W., Qin, C., Lin, S., Khanolkar, A. D., Goutopoulos, A., Fan, P., et al. (1999). Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. Journal of Medicinal Chemistry, 42, 896–902.

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Rodriguez, M. L., Viso, A., Ortega-Gutierrez, S., Lastres-Becker, I., Gonzalez, S., Fernandez-Ruiz, J., et al. (2001). Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. Journal of Medicinal Chemistry, 44, 4505–4508.

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Rodriguez, M. L., Viso, A., Ortega-Gutierrez, S., Fowler, C. J., Tiger, G., de Lago, E., et al. (2003). Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase. Journal of Medicinal Chemistry, 46, 1512–1522.

    Article  PubMed  CAS  Google Scholar 

  • Ortar, G., Ligresti, A., De Petrocellis, L., Morera, E., & Di Marzo, V. (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochemical Pharmacology, 65, 1473–1481.

    Article  PubMed  CAS  Google Scholar 

  • Ortega-Gutierrez, S., Hawkins, E. G., Viso, A., Lopez-Rodriguez, M. L., & Cravatt, B. F. (2004). Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry, 43, 8184–8190.

    Article  PubMed  CAS  Google Scholar 

  • Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X. Q., et al. (1999). Structural determinants for recognition and translocation by the anandamide transporter. Proceedings of the National Academy of Sciences, 96, 5802–5807.

    Article  CAS  Google Scholar 

  • Ruiz-Llorente, L., Ortega-Gutierrez, S., Viso, A., Sanchez, M. G., Sanchez, A. M., Fernandez, C., et al. (2004). Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study. British Journal of Pharmacology, 141, 457–467.

    Article  PubMed  CAS  Google Scholar 

  • Vandevoorde, S., & Fowler, C. J. (2005). Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: Evidence that VDM11 acts as an FAAH substrate. British Journal of Pharmacology, 145, 885–893.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the technical assistance of LeAnna DeLoache and Craig Roelke. These studies were supported by NIH grant DA09155 (CJH and WBC) and NIH GM31278 and the Robert A. Welch Foundation (JRF).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cecilia J. Hillard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hillard, C.J., Shi, L., Tuniki, V. et al. Studies of Anandamide Accumulation Inhibitors in Cerebellar Granule Neurons: Comparison to Inhibition of Fatty Acid Amide Hydrolase. J Mol Neurosci 33, 18–24 (2007). https://doi.org/10.1007/s12031-007-0045-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-007-0045-0

Keywords

Navigation